MMJ PhytoTech Ltd (ASX:MMJ) Harvest One (CVE:HVST) Financing Update

(MENAFN- ABN Newswire) Perth, Nov 21, 2017 AEST (ABN Newswire) - MMJ PhytoTech Limited () ("MMJ" or "the Company") is pleased to advise that TSX-V listed Harvest One Cannabis Inc. () ("Harvest One"), which is 59% owned by MMJ, has released a corporate update in regards to a financing agreement entered into with Mackie Research Capital Corporation.

About Harvest One Cannabis Inc.

Harvest One Cannabis Inc. () controls operations across the entire cannabis value chain through three business units, with Harvest One serving as the umbrella company over horticultural arm United Greeneries and medical arm Satipharm AG. Each business is strategically located in favourable jurisdictions with supportive regulatory frameworks in place. United Greeneries has received a Canadian medicinal cannabis cultivation licence, making Harvest One one of only a few companies globally with the capacity to commercially cultivate cannabis in a federally regulated environment.

To view the full copy of the Harvest One announcement, please visit:



About MMJ PhytoTech Ltd

() is focused on becoming a large-scale cannabis producer, targeting direct supply to the growing Canadian medical and recreational markets which will have an estimated combined value of C$8-9 billion by 2024.

The Company controls operations across the entire medicinal cannabis value chain through its ~59% interest in TSX-V listed Harvest One Cannabis Inc (CVE:HVST) and its 100% interest in Israeli research and development subsidiary, PhytoTech Therapeutics Ltd, both of which are strategically located in favourable jurisdictions with supportive regulatory frameworks in place.

MENAFN2011201701110000ID1096119093